These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36046526)

  • 1. Identification of two novel thiazolidin-2-imines as tyrosinase inhibitors: synthesis, crystal structure, molecular docking and DFT studies.
    Shehzadi SA; Saeed A; Perveen F; Channar PA; Arshad I; Abbas Q; Kalsoom S; Yousaf S; Simpson J
    Heliyon; 2022 Aug; 8(8):e10098. PubMed ID: 36046526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-pot four-component synthesis of thiazolidin-2-imines using Cu
    Shehzadi SA; Khan I; Saeed A; Larik FA; Channar PA; Hassan M; Raza H; Abbas Q; Seo SY
    Bioorg Chem; 2019 Mar; 84():518-528. PubMed ID: 30610971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, kinetic mechanism and molecular docking studies of novel 1-pentanoyl-3-arylthioureas as inhibitors of mushroom tyrosinase and free radical scavengers.
    Larik FA; Saeed A; Channar PA; Muqadar U; Abbas Q; Hassan M; Seo SY; Bolte M
    Eur J Med Chem; 2017 Dec; 141():273-281. PubMed ID: 29040952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper-Catalyzed One-Pot Synthesis of Thiazolidin-2-imines.
    Zorba LP; Stylianakis I; Tsoureas N; Kolocouris A; Vougioukalakis GC
    J Org Chem; 2024 Jun; 89(11):7727-7740. PubMed ID: 38725347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring 3-hydroxyflavone scaffolds as mushroom tyrosinase inhibitors: synthesis, X-ray crystallography, antimicrobial, fluorescence behaviour, structure-activity relationship and molecular modelling studies.
    Ashraf J; Mughal EU; Sadiq A; Bibi M; Naeem N; Ali A; Massadaq A; Fatima N; Javid A; Zafar MN; Khan BA; Nazar MF; Mumtaz A; Tahir MN; Mirzaei M
    J Biomol Struct Dyn; 2021 Nov; 39(18):7107-7122. PubMed ID: 32799758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic and in silico studies of novel hydroxy-based thymol analogues as inhibitors of mushroom tyrosinase.
    Ashraf Z; Rafiq M; Seo SY; Kwon KS; Babar MM; Zaidi NU
    Eur J Med Chem; 2015 Jun; 98():203-11. PubMed ID: 26025140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity-Oriented Synthesis of Thiazolidine-2-imines via Microwave-Assisted One-Pot, Telescopic Approach and Its Interaction with Biomacromolecules.
    Saikia AA; Rao RN; Maiti B; Balamurali MM; Chanda K
    ACS Comb Sci; 2020 Nov; 22(11):630-640. PubMed ID: 32820896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carvacrol derivatives as mushroom tyrosinase inhibitors; synthesis, kinetics mechanism and molecular docking studies.
    Ashraf Z; Rafiq M; Nadeem H; Hassan M; Afzal S; Waseem M; Afzal K; Latip J
    PLoS One; 2017; 12(5):e0178069. PubMed ID: 28542395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, computational studies and enzyme inhibitory kinetics of substituted methyl[2-(4-dimethylamino-benzylidene)-hydrazono)-4-oxo-thiazolidin-5-ylidene]acetates as mushroom tyrosinase inhibitors.
    Channar PA; Saeed A; Larik FA; Rafiq M; Ashraf Z; Jabeen F; Fattah TA
    Bioorg Med Chem; 2017 Nov; 25(21):5929-5938. PubMed ID: 28988751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, computational molecular docking analysis and effectiveness on tyrosinase inhibition of kojic acid derivatives.
    Karakaya G; Türe A; Ercan A; Öncül S; Aytemir MD
    Bioorg Chem; 2019 Jul; 88():102950. PubMed ID: 31075740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, In Silico Studies, and Antioxidant and Tyrosinase Inhibitory Potential of 2-(Substituted Phenyl) Thiazolidine-4-Carboxamide Derivatives.
    Zargaham MK; Ahmed M; Akhtar N; Ashraf Z; Abdel-Maksoud MA; Aufy M; Nadeem H
    Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based designing and synthesis of 2-phenylchromone derivatives as potent tyrosinase inhibitors: In vitro and in silico studies.
    Ashraf J; Mughal EU; Alsantali RI; Obaid RJ; Sadiq A; Naeem N; Ali A; Massadaq A; Javed Q; Javid A; Sumrra SH; Zafar MN; Ahmed SA
    Bioorg Med Chem; 2021 Apr; 35():116057. PubMed ID: 33610011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, kinetic mechanism and docking studies of vanillin derivatives as inhibitors of mushroom tyrosinase.
    Ashraf Z; Rafiq M; Seo SY; Babar MM; Zaidi NU
    Bioorg Med Chem; 2015 Sep; 23(17):5870-80. PubMed ID: 26204890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of thiazolidinone derivatives as a new class of mushroom tyrosinase inhibitors.
    Rezaei M; Mohammadi HT; Mahdavi A; Shourian M; Ghafouri H
    Int J Biol Macromol; 2018 Mar; 108():205-213. PubMed ID: 29180052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of (Z)-2-benzylidene-dihydroimidazothiazolone derivatives as tyrosinase inhibitors: Anti-melanogenic effects and
    Choi H; Young Ryu I; Choi I; Ullah S; Jin Jung H; Park Y; Hwang Y; Jeong Y; Hong S; Chun P; Young Chung H; Ryong Moon H
    Comput Struct Biotechnol J; 2022; 20():899-912. PubMed ID: 35242283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis, Pharmacological Activities, Structure-Activity Relationship, and In Silico Studies of Novel 5-Substituted-2-(morpholinoimino)-thiazolidin-4-ones.
    Sıcak Y; Aktar BSK; Yılmaz GT; Öztürk FA; Öztürk M; Tok TT; Emre EEO
    ACS Omega; 2023 Oct; 8(41):38641-38657. PubMed ID: 37867693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, molecular docking and kinetic studies of novel quinolinyl based acyl thioureas as mushroom tyrosinase inhibitors and free radical scavengers.
    Mustafa MN; Saeed A; Channar PA; Larik FA; Zain-Ul Abideen M; Shabir G; Abbas Q; Hassan M; Raza H; Seo SY
    Bioorg Chem; 2019 Sep; 90():103063. PubMed ID: 31220666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as novel tyrosinase inhibitors.
    Ha YM; Park YJ; Kim JA; Park D; Park JY; Lee HJ; Lee JY; Moon HR; Chung HY
    Eur J Med Chem; 2012 Mar; 49():245-52. PubMed ID: 22301213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial Tyrosinase Inhibition, Hemolytic and Thrombolytic Screening, and In Silico Modeling of Rationally Designed Tosyl Piperazine-Engrafted Dithiocarbamate Derivatives.
    Zahoor AF; Hafeez F; Mansha A; Kamal S; Anjum MN; Raza Z; Khan SG; Javid J; Irfan A; Bhat MA
    Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Based Design, Synthesis, Biological Evaluation and Molecular Docking Study of 4-Hydroxy-N'-methylenebenzohydrazide Derivatives Acting as Tyrosinase Inhibitors with Potentiate Anti-Melanogenesis Activities.
    Iraji A; Khoshneviszadeh M; Bakhshizadeh P; Edraki N; Khoshneviszadeh M
    Med Chem; 2020; 16(7):892-902. PubMed ID: 31339074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.